UBS Group’s Soligenix SNGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-2,346
| Closed | -$2.77K | – | 10994 |
|
|
2026
Q1 | $2.77K | Sell |
2,346
-31,668
| -93% | -$39K | ﹤0.01% | 9206 |
|
|
2025
Q4 | $45.6K | Buy |
34,014
+33,831
| +18,487% | +$50.2K | ﹤0.01% | 7276 |
|
|
2025
Q3 | $212 | Sell |
183
-19,240
| -99% | -$44.2K | ﹤0.01% | 9806 |
|
|
2025
Q2 | $25.4K | Buy |
19,423
+8,954
| +86% | +$16.9K | ﹤0.01% | 8285 |
|
|
2025
Q1 | $22.5K | Buy |
10,469
+10,156
| +3,245% | +$24.8K | ﹤0.01% | 8148 |
|
|
2024
Q4 | $844 | Buy |
+313
| New | +$1.1K | ﹤0.01% | 9367 |
|
|
2024
Q3 | – | Sell |
-6,231
| Closed | -$16.1K | – | 10025 |
|
|
2024
Q2 | $16.1K | Buy |
6,231
+6,142
| +6,901% | +$35.4K | ﹤0.01% | 7448 |
|
|
2024
Q1 | $857 | Buy |
+89
| New | +$1K | ﹤0.01% | 8338 |
|
|
2023
Q3 | – | Sell |
-112
| Closed | -$1.26K | – | 9928 |
|
|
2023
Q2 | $1.26K | Buy |
+112
| New | +$1.95K | ﹤0.01% | 7965 |
|
|
2023
Q1 | – | Sell |
-19
| Closed | -$2.05K | – | 10307 |
|
|
2022
Q4 | $2.05K | Sell |
19
-42
| -69% | -$6.07K | ﹤0.01% | 9743 |
|
|
2022
Q3 | $6K | Buy |
+61
| New | +$10.7K | ﹤0.01% | 9061 |
|
|
2022
Q2 | – | Sell |
-27
| Closed | -$5K | – | 10891 |
|
|
2022
Q1 | $5K | Sell |
27
-66
| -71% | -$10.6K | ﹤0.01% | 9164 |
|
|
2021
Q4 | $15K | Buy |
93
+59
| +174% | +$12.7K | ﹤0.01% | 8260 |
|
|
2021
Q3 | $9K | Buy |
+34
| New | +$8.29K | ﹤0.01% | 8112 |
|
|
2021
Q2 | – | Sell |
-8
| Closed | -$3K | – | 9781 |
|
|
2021
Q1 | $3K | Buy |
+8
| New | +$3.18K | ﹤0.01% | 8536 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 8720 |
|
|
2020
Q3 | – | Sell |
-14
| Closed | -$6.91K | – | 8377 |
|
|
2020
Q2 | $7K | Buy |
+14
| New | +$5.77K | ﹤0.01% | 7231 |
|
|
2020
Q1 | – | Sell |
-4
| Closed | -$2.27K | – | 8365 |
|
|
2019
Q4 | $1K | Sell |
4
-24
| -86% | -$6.05K | ﹤0.01% | 7980 |
|
|
2019
Q3 | $6K | Sell |
28
-5
| -15% | -$1.24K | ﹤0.01% | 7425 |
|
|
2019
Q2 | $6K | Sell |
33
-19
| -37% | -$3.43K | ﹤0.01% | 7321 |
|
|
2019
Q1 | $11K | Buy |
52
+10
| +24% | +$2.26K | ﹤0.01% | 6758 |
|
|
2018
Q4 | $9K | Buy |
42
+41
| +4,100% | +$11.6K | ﹤0.01% | 7290 |
|
|
2018
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 8246 |
|
|
2018
Q2 | $0 | Sell |
1
-9
| -90% | -$3.45K | ﹤0.01% | 8220 |
|
|
2018
Q1 | $5K | Buy |
+10
| New | +$5.02K | ﹤0.01% | 7244 |
|
|
2017
Q4 | – | Sell |
-9
| Closed | -$4.55K | – | 8075 |
|
|
2017
Q3 | $5K | Sell |
9
-1
| -10% | -$534 | ﹤0.01% | 7233 |
|
|
2017
Q2 | $5K | Sell |
10
-16
| -62% | -$9.84K | ﹤0.01% | 7133 |
|
|
2017
Q1 | $17K | Buy |
26
+18
| +225% | +$10.5K | ﹤0.01% | 6271 |
|
|
2016
Q4 | $5K | Buy |
+8
| New | +$4.64K | ﹤0.01% | 7252 |
|
Other funds holding SNGX
XT
VF
UBS Group's SNGX Position: Q2 2026 in Review
UBS Group sold out of Soligenix (SNGX) in Q2 2026, closing a stake of 2,346 shares — an estimated $2.77K sold.
UBS Group first reported a position in SNGX in Q4 2016 and held it in 28 quarters. The position peaked at $45.6K in Q4 2025. 17 funds tracked by Wall St. Rank hold SNGX as of Q2 2026.
- UBS Group reported no remaining Soligenix position as of Q2 2026 after selling out during the quarter.
- UBS Group sold 2,346 Soligenix shares in Q2 2026, an estimated $2.77K.
- UBS Group first reported a position in Soligenix in Q4 2016 and held it in 28 quarters.
- UBS Group's Soligenix position peaked at $45.6K in Q4 2025.
- 17 funds tracked by Wall St. Rank held Soligenix as of Q2 2026.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.